Dianthus Therapeutics Inc (NASDAQ: DNTH) is -16.38% lower on its value in year-to-date trading and has touched a low of $13.36 and a high of $32.27 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNTH stock was last observed hovering at around $18.25 in the last trading session, with the day’s gains setting it 2.84%.
Currently trading at $21.09, the stock is 15.53% and 11.59% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing 15.56% at the moment leaves the stock -5.48% off its SMA200. DNTH registered -3.26% loss for a year compared to 6-month loss of -16.04%. The firm has a 50-day simple moving average (SMA 50) of $18.8992 and a 200-day simple moving average (SMA200) of $22.3118.
The stock witnessed a 11.88% gain in the last 1 month and extending the period to 3 months gives it a 35.11%, and is 17.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.84% over the week and 7.30% over the month.
Dianthus Therapeutics Inc (DNTH) has around 78 employees, a market worth around $678.25M and $6.52M in sales. Profit margin for the company is -1544.02%. Distance from 52-week low is 57.80% and -34.65% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.55%).
The EPS is expected to shrink by -30.86% this year
143.0 institutions hold shares in Dianthus Therapeutics Inc (DNTH), with institutional investors hold 130.11% of the company’s shares. The shares outstanding are 32.13M, and float is at 22.32M with Short Float at 29.96%. Institutions hold 119.87% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.4 million shares valued at $113.93 million. The investor’s holdings represent 12.8624 of the DNTH Shares outstanding. As of 2024-06-30, the second largest holder is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with 3.01 million shares valued at $77.99 million to account for 8.8042 of the shares outstanding. The other top investors are AVIDITY PARTNERS MANAGEMENT LP which holds 2.92 million shares representing 8.5232 and valued at over $75.5 million, while FAIRMOUNT FUNDS MANAGEMENT LLC holds 8.0721 of the shares totaling 2.76 million with a market value of $71.5 million.
